NCT00688103View on ClinicalTrials.gov

Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan

PHASE4CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2010

Conditions
Rheumatoid Arthritis
Interventions
DRUG

ETN Alone

etanercept (25 mg, twice/week, s.c.)

DRUG

ETN+MTX

etanercept (25 mg, twice/week, s.c.) combined with methotrexate (6-8 mg/week)

Trial Locations (1)

160-8582

Keio University, Tokyo

All Listed Sponsors
lead

Japan Biological Agent Study Integrated Consortium

NETWORK

NCT00688103 - Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan | Biotech Hunter | Biotech Hunter